This protocol is to provide follow-up medical/surgical visits for DCS patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigational treatments or standard treatments will be administered on this protocol.

Condition
Acquired Immunodeficiency Syndrome Neoplasm Skin Disease HIV Infections

Further Study Details: 

Expected Total Enrollment:  620

This protocol is to provide follow-up medical surgical visits for Center for Cancer Research (CCR) patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigational treatments or standard treatments will be administered on this protocol.

Genders Eligible for Study:  Both

Criteria

ELIGIBILITY CRITERIA:
Previously enrolled on a CCR/(NCI-NMB) protocol.
Not eligible for an active NCI intramural primary research protocol.
CCR/(NCI-NMB) investigator decides it is in the best interests of the patient and the CCR/(NCI-NMB) for the patient to be seen in follow-up visits at the NIH.
Written memo, signed by the Branch Chief, to the NCI Principal Investigator requesting entry of patient onto protocol.
Patient or guardian is able to provide informed consent.

Maryland
      National Cancer Institute (NCI), 9000 Rockville Pike,  Bethesda,  Maryland,  20892,  United States; Recruiting

Study ID Numbers:  960071; 96-C-0071
Record last reviewed:  February 1, 2005
Last Updated:  February 3, 2005
Record first received:  November 3, 1999
ClinicalTrials.gov Identifier:  NCT00001503
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08